Press release
Just how serious is OxyContin addiction? Pharmaceutical company fined over $630 million dollars for misleading the public on addiction risk
Since its introduction in 1995, the pain killer OxyContin has resulted in increasingpatterns of abuse. It became one of the most powerful and most addictive street drugs and, for years, doctors prescribed the pain killer without knowing how addicting it really was. Hundreds of people have died as a direct result of their addiction to OxyContin.
According to the DEA, in 2002 alone, OxyContin caused 146 deaths and contributed to another 318. Doctors prescribe the popular pain medication because they were told by its manufacturer Purdue Pharma that the drug was less addictive and less prone to abuse then any other pain killers on the market. Despite these problems, OxyContin had become one of the leading opioid painkillers on the market. In 2001, OxyContin was the highest sold drug of its kind, and in 2000, over 6.5 million prescriptions were written, according to the Drug Policy Alliance (http://www.drugpolicy.org/drugbydrug/oxycontin/).
Last week, a United States district court had a different opinion. After hours in court and testimonies from former OxyContin addicts and family members of those who had died from OxyContin, U.S. District Judge James Jones imposed a fine of $634,5 million dollars and criminal charges against company officers of Purdue Pharma L.P. Officers of the company were charged with misbranding the drug. Over the years they heavily downplayed the risk of OxyContin, with horrific results to many families. Hundreds of addicts have died as a result of the drugs widespread availability. A memorial site (http://www.oxyabusekills.com) lists many victims, often young people in their prime.
OxyContin caused just as many problems for patients trying to overcome pain as it did for drug users. Many patients found that the pain of OxyContin withdrawl was far worse then the pain they were being treatment for, according to a spokesperson for ChooseHelp Treatment Centers (http://www.choosehelp.com) – a renowned rehab provider that offers specialized OxyContin treatment programs.
ChooseHelp.com is a drug-rehab referral website that offers highly successful treatment for OxyContin and other substances, with centers based in Laguna Beach, California and St Beach, Florida.
ChooseHelp.com
100 S. Point Drive
No.: 1207
Miami Beach, FL 33139
U.S.A.
www.ChooseHelp.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Just how serious is OxyContin addiction? Pharmaceutical company fined over $630 million dollars for misleading the public on addiction risk here
News-ID: 24486 • Views: …
More Releases from ChooseHelp.com

Teen drug rehab reports cites important drug abuse issues for parents to deal wi …
The teenage years can be a challenging and confusing time. The bad news is that almost a quarter of American youngsters abuse drugs at this stage of their lives. Some get involved in a recreational manor, some experiment out of peer pressure. The good news is that it is much easier to curb addiction patterns in a young person.
The longer one waits to deal with addiction issues the harder…

Executive drug rehab - How depression, drugs and alcohol creep into the lives of …
Why do high achievers like doctors and lawyers, politicians and professional athletes, famous actors and rock stars, business owners and executives succumb to drugs, alcohol, and depression? The answer is simpler than you might think. Recent results from surveys and research conducted by the drug treatment website ChooseHelp.com have shown highly productive people have made up the majority of the populations at many drug/alcohol treatment centers.
When a hard worker…

Lohan and Spears recent rehab stints result in major increase of treatment admis …
Miami Beach, FL - The nations top drug treatment centers are experiencing a high increase in admissions over the past two months. The majority of the new patients credit their decision to seek help at a treatment center due to the high profile celebrity figures also admitting their addiction and seeking help. The new patients who have felt that they may have had a drinking or drug problem in the…
More Releases for OxyContin
Oxycodone (OxyContin) Manufacturing Plant Project Report 2024 Edition, Requireme …
IMARC Group's report titled "𝐎𝐱𝐲𝐜𝐨𝐝𝐨𝐧𝐞 (𝐎𝐱𝐲𝐂𝐨𝐧𝐭𝐢𝐧) 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐏𝐥𝐚𝐧𝐭 𝐏𝐫𝐨𝐣𝐞𝐜𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟒: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐏𝐥𝐚𝐧𝐭 𝐒𝐞𝐭𝐮𝐩, 𝐌𝐚𝐜𝐡𝐢𝐧𝐞𝐫𝐲, 𝐑𝐚𝐰 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬, 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬, 𝐂𝐨𝐬𝐭 𝐚𝐧𝐝 𝐑𝐞𝐯𝐞𝐧𝐮𝐞" provides a comprehensive guide for establishing a oxycodone (OxyContin) manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more.
In addition to…
What's the next big thing in the Oxycodone Market...? Pfizer Inc., Teva Pharmace …
Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019. Future Market Insights, in its recent analysis of the global oxycodone market, elaborates on the key market dynamics, opportunity assessment, and regional and competitive landscape analysis, for a period spanning 2018 to…
Oxycodone Market Growth by 2028 Key Leading Key Players: Purdue Pharma L.P, Daii …
Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019. Future Market Insights, in its recent analysis of the global oxycodone market, elaborates on the key market dynamics, opportunity assessment, and regional and competitive landscape analysis, for a period spanning 2018 to…
Oxycodone Market 2018 - 2028 | Key Players include Pfizer Inc., Teva Pharmaceuti …
Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019. Future Market Insights, in its recent analysis of the global oxycodone market, elaborates on the key market dynamics, opportunity assessment, and regional and competitive landscape analysis, for a period spanning 2018 to 2028.
With nearly 10-fold…
Controlled Substances Market - Global Industry Volume 2017 to 2025
Pharmaceutical industry has many segments of drugs which is used in manufacturing of tablets, capsules and other treatment products. Some of the drugs are legal, which can used for manufacturing but some of the drugs are illegal, which cannot be used by pharmaceutical industry for manufacturing and the drugs are also not available in the market, without proper permission from respective government associations. Controlled substances come under illegal drugs which…
Global Opioids Drugs Market Research Report 2017
Global Opioids Drug Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020.
The cumulative effect of diverse factors has been responsible behind the stability of the global Opioids Drug market. While there are a few factors creating hindrances for the market, overall the stability is expected to remain intact through the course of the forecast period between 2017 and 2021.…